Displaying results 1 - 1 of 1
Clear search
Camallergy awarded £1.1m Innovate UK funding for novel peanut allergy treatment
Cambridge Allergy Ltd (Camallergy), a biopharmaceutical company dedicated to providing innovative, patient-centric treatments for life-threatening food allergies, today announced it has been awarded £1.1million funding under the Innovate UK Biomedical Catalyst Award programme administered by Innovate UK, the United Kingdom’s research and innovation agency.